Literature DB >> 17597354

Preparation and endothelialization of decellularised vascular scaffold for tissue-engineered blood vessel.

Xi-xun Yu1, Chang-xiu Wan, Huai-qing Chen.   

Abstract

The proliferation of cells on the decellularised tissues fixed by chemical crosslinking agent is retarded for cytotoxicity of crosslinked tissues. To overcome this disadvantage, we prepared the decellularised vascular scaffold through fixing the porcine thoracic arteries with 40 mL/L ethylene glycol diglycidyl ether (EGDE), and reduced the cytotoxicity of this scaffold by treating it with lysine and coating it with type I collagen, finally endothelialized it in vitro. The EGDE-fixed porcine thoracic arteries were examined morphologically. The fixation index determination and the biomechanics test were also performed. Human umbilical vein endothelial cells (HUVECs) were seeded on the type I collagen-coated surface of different modified vascular tissues (fixed with glutaraldehyde or EGDE or EGDE + lysine), and the growths of HUVECs on the specimens were demonstrated by means of MTT test. Finally, HUVECs were seeded on the luminal surface of the modified porcine vascular scaffolds which were respectively treated in the same manner described above, and then cultured for 7 days. On the seventh day, the HUVECs on the specimens were examined by means of light microscopy, scanning electron microscopy and transmission electron microscopy (TEM). The antigenicity of the vascular tissues can be diminished by EGDE through getting rid of cell in the vascular tissues or reducing the level of free amino groups in the vascular tissues. In this study, it was also found that the EGDE-fixed porcine vascular tissues appeared similar to the native porcine vascular tissues in color and mechanical properties. After treated by 2% lysine and coated with type I collagen, the EGDE-fixed porcine vascular tissues were characterized by low cytotoxicity and good cytocompatible. The HUVECs can proliferate well on the modified vascular tissues, and easily make it endothelialized. The results showed that the modified porcine vascular scaffolds should be a promising material for fabricating scaffold of tissue-engineered blood vessel.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17597354     DOI: 10.1007/s10856-007-3157-8

Source DB:  PubMed          Journal:  J Mater Sci Mater Med        ISSN: 0957-4530            Impact factor:   3.896


  11 in total

1.  Crosslinking characteristics and mechanical properties of a bovine pericardium fixed with a naturally occurring crosslinking agent.

Authors:  H W Sung; Y Chang; C T Chiu; C N Chen; H C Liang
Journal:  J Biomed Mater Res       Date:  1999-11

Review 2.  Tissue engineering: the design and fabrication of living replacement devices for surgical reconstruction and transplantation.

Authors:  J P Vacanti; R Langer
Journal:  Lancet       Date:  1999-07       Impact factor: 79.321

Review 3.  Acellular vascular tissues: natural biomaterials for tissue repair and tissue engineering.

Authors:  C E Schmidt; J M Baier
Journal:  Biomaterials       Date:  2000-11       Impact factor: 12.479

4.  Coronary heart disease in the first 30 years of the 21st century: challenges and opportunities: The 33rd Annual James B. Herrick Lecture of the Council on Clinical Cardiology of the American Heart Association.

Authors:  G A Beller
Journal:  Circulation       Date:  2001-05-22       Impact factor: 29.690

Review 5.  Tissue engineering of small diameter vascular grafts.

Authors:  Omke E Teebken; Axel Haverich
Journal:  Eur J Vasc Endovasc Surg       Date:  2002-06       Impact factor: 7.069

6.  Feasibility study of a natural crosslinking reagent for biological tissue fixation.

Authors:  H W Sung; R N Huang; L L Huang; C C Tsai; C T Chiu
Journal:  J Biomed Mater Res       Date:  1998-12-15

7.  Prior peripheral arterial disease and cerebrovascular disease are independent predictors of adverse outcome in patients with acute coronary syndromes: are we doing enough? Results from the Orbofiban in Patients with Unstable Coronary Syndromes-Thrombolysis In Myocardial Infarction (OPUS-TIMI) 16 study.

Authors:  Gad Cotter; Christopher P Cannon; Carolyn H McCabe; Yoav Michowitz; Edo Kaluski; Andrew Charlesworth; Olga Milo; Jane Bentley; Alex Blatt; Rikardo Krakover; Reuven Zimlichman; Leonardo Reisin; Alon Marmor; Basil Lewis; Zvi Vered; Avi Caspi; Eugene Braunwald
Journal:  Am Heart J       Date:  2003-04       Impact factor: 4.749

8.  In vitro evaluation of cytotoxicity of diepoxy compounds used for biomaterial modification.

Authors:  C Nishi; N Nakajima; Y Ikada
Journal:  J Biomed Mater Res       Date:  1995-07

9.  Fixation of bioprosthetic tissues with monofunctional and multifunctional polyepoxy compounds.

Authors:  R Tu; S H Shen; D Lin; C Hata; K Thyagarajan; Y Noishiki; R C Quijano
Journal:  J Biomed Mater Res       Date:  1994-06

10.  Effect of vascular endothelial growth factor and epidermal growth factor on iatrogenic apoptosis in human endothelial cells.

Authors:  Maria Cristina Vinci; Barbara Visentin; Federico Cusinato; Giovanni Battista Nardelli; Lucia Trevisi; Sisto Luciani
Journal:  Biochem Pharmacol       Date:  2004-01-15       Impact factor: 5.858

View more
  9 in total

1.  In vitro study in the endothelial cell compatibility and endothelialization of genipin-crosslinked biological tissues for tissue-engineered vascular scaffolds.

Authors:  Yu Xi-xun; Liu Fei; Xu Yuan-ting; Wan Chang-xiu
Journal:  J Mater Sci Mater Med       Date:  2010-02       Impact factor: 3.896

2.  Extruded collagen fibres for tissue engineering applications: effect of crosslinking method on mechanical and biological properties.

Authors:  Davide Enea; Frances Henson; Simon Kew; John Wardale; Alan Getgood; Roger Brooks; Neil Rushton
Journal:  J Mater Sci Mater Med       Date:  2011-05-10       Impact factor: 3.896

3.  The influence of early-phase remodeling events on the biomechanical properties of engineered vascular tissues.

Authors:  Zehra Tosun; Carolina Villegas-Montoya; Peter S McFetridge
Journal:  J Vasc Surg       Date:  2011-08-27       Impact factor: 4.268

4.  Tissue Engineering of Blood Vessels: Functional Requirements, Progress, and Future Challenges.

Authors:  Vivek A Kumar; Luke P Brewster; Jeffrey M Caves; Elliot L Chaikof
Journal:  Cardiovasc Eng Technol       Date:  2011-09-01       Impact factor: 2.495

5.  In Vivo Remodeling of Fibroblast-Derived Vascular Scaffolds Implanted for 6 Months in Rats.

Authors:  Maxime Y Tondreau; Véronique Laterreur; Karine Vallières; Robert Gauvin; Jean-Michel Bourget; Catherine Tremblay; Dan Lacroix; Lucie Germain; Jean Ruel; Francois A Auger
Journal:  Biomed Res Int       Date:  2016-11-24       Impact factor: 3.411

6.  Genipin and EDC crosslinking of extracellular matrix hydrogel derived from human umbilical cord for neural tissue repair.

Authors:  Karel Výborný; Jana Vallová; Zuzana Kočí; Kristýna Kekulová; Klára Jiráková; Pavla Jendelová; Jiří Hodan; Šárka Kubinová
Journal:  Sci Rep       Date:  2019-07-23       Impact factor: 4.379

Review 7.  Building Scaffolds for Tubular Tissue Engineering.

Authors:  Alexander J Boys; Sarah L Barron; Damyan Tilev; Roisin M Owens
Journal:  Front Bioeng Biotechnol       Date:  2020-12-10

8.  Tough and tissue-adhesive polyacrylamide/collagen hydrogel with dopamine-grafted oxidized sodium alginate as crosslinker for cutaneous wound healing.

Authors:  Zhongxiang Bai; Weihua Dan; Guofei Yu; Yanjun Wang; Yining Chen; Yanping Huang; Changkai Yang; Nianhua Dan
Journal:  RSC Adv       Date:  2018-12-18       Impact factor: 4.036

9.  Physico-Chemical Characterization and Biological Tests of Collagen/Silk Fibroin/Chitosan Scaffolds Cross-Linked by Dialdehyde Starch.

Authors:  Sylwia Grabska-Zielińska; Alina Sionkowska; Katarzyna Reczyńska; Elżbieta Pamuła
Journal:  Polymers (Basel)       Date:  2020-02-07       Impact factor: 4.329

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.